BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Neurocrine Biosciences Announces Conference Call and Webcast to Report Third Quarter 2017 Results

  Neurocrine announced today that the Company will report third quarter 2017 results after the Nasdaq market close on November 1, 2017.

  October 25, 2017

   · 

  1 min read
• Business

  Amgen Announces 2017 Fourth Quarter Dividend

  Amgen today announced that its Board of Directors declared a $1.15 per share dividend for the fourth quarter of 2017.

  October 25, 2017

   · 

  5 min read
• Business

  Jazz Pharma to Report 2017 Third Quarter Financial Results on November 7, 2017

  Jazz Pharma today announced that it will report its 2017 third quarter financial results on Tuesday, November 7, 2017, after the close of the financial markets.

  October 25, 2017

   · 

  1 min read
• Business

  NuVasive Reports Third Quarter 2017 Financial Results

  NuVasive announced today financial results for the quarter ended September 30, 2017.

  October 25, 2017

   · 

  51 min read
• 

  BioMidwest

  ViewRay Scores $50M in Stock Sale

  The purchase price for each share was $5.95, approximately equal to the trailing 30-day average price at the time of negotiation.

  October 25, 2017

   · 

  3 min read
• Business

  Alligator Bioscience Interim Report January-September 2017

  Three important collaborations in place. Results in November from ADC-1013 clinical phase I study.

  October 25, 2017

   · 

  4 min read
• The Scripps Research Institute New Study: ‘Double Decker’ Antibody Technology Fights Cancer

  Scientists from the Florida campus of The Scripps Research Institute have created a new class of ADCs, using a versatile “double decker""technology that ties antibodies and a drug together to produce highly potent pharmaceuticals for cancer therapy.

  October 25, 2017

   · 

  3 min read
• Business

  United Therapeutics Corporation Reports Third Quarter 2017 Financial Results

  United Therapeutics today announced its financial results for the third quarter ended September 30, 2017.

  October 25, 2017

   · 

  20 min read
• Business

  Cogentix Medical to Report Third Quarter Results on November 7, 2017

  Cogentix Medical, a global medical device company focused on providing the Urology, Uro/Gyn and Gynecology markets with innovative and proprietary products, will release financial results for the third quarter ended September 30, 2017 after the market close on Tuesday, November 7, 2017.

  October 25, 2017

   · 

  2 min read
• Business

  Aralez to Report Third Quarter 2017 Financial Results on November 9, 2017

  Aralez today announced that it will report its third quarter 2017 financial results on Thursday, November 9, 2017, before the opening of the U.S. financial markets.

  October 25, 2017

   · 

  1 min read